Feasibility of Induction Docetaxel, Cisplatin, 5-Fluorouracil, Cetuximab (TPF-C) Followed by Concurrent Cetuximab Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma.

Charalambakis, Nikolaos; Kouloulias, Vassilis; Vaja, Helena; Pectasides, Dimitrios; Rampias, Theodoros; Economopoulos, Theofanis; Katsaounis, Panagiotis; Siolos, Spiros; Bartzi, Valentina; Perisanidis, Christos; Laschos, Konstantinos; Maragoudakis, Pavlos; Proikas, Konstantinos; Papadimitriou, Nikolaos; Papadogeorgakis, Nikolaos; Georgopoulou, Helen; Zygogianni, Anna; Artopoulou, Ioli; Pappa, Eleni; Dimitriadis, George; Psyrri, Amanda

Charalambakis, Nikolaos; Kouloulias, Vassilis; Vaja, Helena; Pectasides, Dimitrios; Rampias, Theodoros; Economopoulos, Theofanis; Katsaounis, Panagiotis; Siolos, Spiros; Bartzi, Valentina; Perisanidis, Christos; Laschos, Konstantinos; Maragoudakis, Pavlos; Proikas, Konstantinos; Papadimitriou, Nikolaos; Papadogeorgakis, Nikolaos; Georgopoulou, Helen; Zygogianni, Anna; Artopoulou, Ioli; Pappa, Eleni; Dimitriadis, George; Psyrri, Amanda.

Afiliación

Charalambakis N; Second Department of Internal Medicine Propaedeutic, Oncology Section, Attikon University Hospital, University of Athens Medical School Athens, Greece.

Front Oncol ; 3: 5, 2013.

Article en En | MEDLINE | ID: mdl-23373010

Palabras clave

HNSCC; PIK3CA, HPV DNA; TPF-C; cetuximab radiotherapy; mutation analysis; toxicity and outcome

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2013 Tipo del documento: Article País de afiliación: Grecia Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google